Abstract
1047O - Baseline tumor T cell receptor (TcR) sequencing analysis and neo antigen load is associated with benefit in melanoma patients receiving sequential nivolumab and ipilimumab
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have